All lobbying filings
MEHLMAN CONSULTING, INC.
Lobbying for ULTRAGENYX PHARMACEUTICAL, INC. · Biopharmaceutical Company
Filing
2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
California
Lobbyists on this filing
1
-
JON ADAME New on this filingPreviously held: CoS, LD, GC (Sen. Blackburn); Counsel (Rep. Blackburn); Policy Coordinator (House E&C); Intern (Sen. Domenici)
Government bodies contacted
2
Lobbying activity
1
Issues relating to rare disease and patient access. H.R.1262/S. 932 - Give Kids a Chance Act of 2025. H.R.1509/S. 752 - Accelerating Kids Access to Care Act of 2025. H.R. 1 - One Big Beautiful Bill Act.